{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:08:31Z","timestamp":1789110511698,"version":"build-2803163510"},"reference-count":0,"publisher":"Longwoods Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["hcpol"],"DOI":"10.12927\/hcpol.2026.27900","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:57:16Z","timestamp":1789109836000},"page":"57-63","source":"Crossref","is-referenced-by-count":0,"title":["Should Health Canada Use Reports from Foreign Regulators to Approve New Drugs?"],"prefix":"10.12927","volume":"21","author":[{"given":"Joel","family":"Lexchin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5072","published-online":{"date-parts":[[2026,8,21]]},"container-title":["Healthcare Policy | Politiques de Sant\u00e9"],"original-title":[],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:57:19Z","timestamp":1789109839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.longwoods.com\/content\/27900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.12927\/hcpol.2026.27900","relation":{},"ISSN":["1715-6580"],"issn-type":[{"value":"1715-6580","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}